Similar articles

• [Growth factors, carbohydrate and lipid metabolism in females with polycystic ovary syndrome].

  Urdl W, Desoye G, Schmon B, Hofmann HM, Hönigl W. Urdl W, et al. Gynakol Rundsch. 1988;28 Suppl 2:211-3. Gynakol Rundsch. 1988. PMID: 3069626 German. No abstract available.
• Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome.

  Norman RJ, Hague WM, Masters SC, Wang XJ. Norman RJ, et al. Hum Reprod. 1995 Sep;10(9):2258-61. doi: 10.1093/oxfordjournals.humrep.a136280. Hum Reprod. 1995. PMID: 8530647
• Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.

  Barrea L, Marzullo P, Muscogiuri G, Di Somma C, Scacchi M, Orio F, Aimaretti G, Colao A, Savastano S. Barrea L, et al. Nutr Res Rev. 2018 Dec;31(2):291-301. doi: 10.1017/S0954422418000136. Epub 2018 Jul 23. Nutr Res Rev. 2018. PMID: 30033891 Review.
• Insulin resistance in polycystic ovary syndrome.

  Prelevic GM. Prelevic GM. Curr Opin Obstet Gynecol. 1997 Jun;9(3):193-201. Curr Opin Obstet Gynecol. 1997. PMID: 9263704 Review.
• Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.

  Legro RS, Kunselman AR, Dunaif A. Legro RS, et al. Am J Med. 2001 Dec 1;111(8):607-13. doi: 10.1016/s0002-9343(01)00948-2. Am J Med. 2001. PMID: 11755503